Research Blends
APX-RTA3 + Tirzepatide
$130.00
Form Research vialUse Laboratory research onlyDocumentation COA request available
Two-compound research blend of APX-RTA3 and tirzepatide, labeled by per-compound content for incretin-receptor research.
01Research-only labeling
02Order review before payment
03Lot-document support
Research Overview +
Two-compound research blend of APX-RTA3 and tirzepatide, labeled by per-compound content for incretin-receptor research.
This summary is educational and does not establish safety, effectiveness, dosing, or an approved use.
Specifications +
| Product | APX-RTA3 + Tirzepatide |
|---|---|
| Available formulation(s) | 60 mg (20 mg + 40 mg) |
| Category | Research Blends |
| Intended use | Laboratory research only |
Documentation & COA +
Need lot-specific documentation? Use the COA Library or contact APEX support with the product name and lot number.
Open COA LibraryResearch Use Notice +
Not for human or veterinary use. No dosing, injection, administration, treatment, or medical guidance is provided on this page.
Related Research Area
